Stonebridge Capital Management’s Pfizer PFE Stock Holding History

Stonebridge Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$983K	Sell	40,827 -9,662	-19%	-$253K	0.47%	41
2026 Q1	$1.42M	Buy	+50,489	New	+$1.34M	0.64%	37
2025 Q2	$1.56M	Sell	64,559 -2,560	-4%	-$59.7K	0.61%	37
2025 Q1	$1.7M	Sell	67,119 -4,840	-7%	-$127K	0.74%	33
2024 Q4	$1.91M	Sell	71,959 -2,305	-3%	-$62.5K	0.78%	32
2024 Q3	$2.15M	Sell	74,264 -341	-0.5%	-$9.95K	0.85%	32
2024 Q2	$2.09M	Sell	74,605 -155	-0.2%	-$4.27K	0.89%	32
2024 Q1	$2.08M	Sell	74,760 -3,593	-5%	-$99.7K	0.93%	33
2023 Q4	$2.26M	Buy	+78,353	New	+$2.37M	1.1%	27

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stonebridge Capital Management's PFE Position: Q2 2026 in Review

Stonebridge Capital Management reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $253K and leaving 40,827 shares worth $983K. The position accounts for 0.47% of the portfolio, ranked #41.

Stonebridge Capital Management first reported a position in PFE in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.26M in Q4 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Stonebridge Capital Management held 40,827 shares of Pfizer worth $983K as of Q2 2026.
Stonebridge Capital Management sold 9,662 Pfizer shares in Q2 2026, an estimated $253K.
Pfizer made up 0.47% of Stonebridge Capital Management's portfolio in Q2 2026, its #41 holding.
Stonebridge Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 9 quarters since.
Stonebridge Capital Management's Pfizer position peaked at $2.26M in Q4 2023.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stonebridge Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.